Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02061579 · ClinicalTrials.gov registry record · NA

Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study

A NA study of Diabetes Mellitus, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
354
Enrollment target
1
Study location

NCT02061579 is a NA study of Diabetes Mellitus that has completed, run by Stanford University. The registered enrollment target is 354 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02061579, a NA study of Diabetes Mellitus, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
354 participants
Enrollment target
1
Study location

Study Summary

The Initiate and Maintain Physical Activity in Clinics (IMPACT) study will determine the optimal and feasible level of frequency of structured contact needed in a clinical setting for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity recommendations long-term.

Conditions Studied

Interventions

  • BEHAVIORAL Structured Group Exercise

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 354 participants
Start Date 2016-10
Est. Completion 2020-01
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02061579

The ClinicalTrials.gov registry entry for NCT02061579 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 354 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (81% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Structured Group Exercise is the first listed.

NCT02061579 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02061579 about?

NCT02061579 is a clinical study titled "Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study". The Initiate and Maintain Physical Activity in Clinics (IMPACT) study will determine the optimal and feasible level of frequency of structured contact needed in a clinical setting for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity recommendations long-term.

What is the current status of trial NCT02061579?

This trial is currently completed. It is a NA study. The enrollment target is 354 participants. The study started on 2016-10. Estimated completion is 2020-01.

What conditions does trial NCT02061579 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT02061579?

The interventions under investigation include: Structured Group Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT02061579?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02061579 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.